Concentration is expressed as milligrams per milliliter (mg/mL)
Metabolic indicators that may be associated with reduced GLP-1 activity include: Persistent elevated blood glucose levels , particularly postprandial (after-meal) hyperglycaemia Difficulty achieving or maintaining a healthy weight despite dietary efforts Increased appetite and reduced satiety after meals, leading to frequent snacking Diagnosis of type 2 diabetes or non-diabetic hyperglycaemia (NDH, sometimes called prediabetes), conditions where GLP-1 response is often blunted Features of metabolic syndrome , including central obesity, hypertension, and dyslipidaemia Individuals may also notice practical symptoms such as feeling hungry shortly after eating substantial meals, experiencing energy crashes following carbohydrate-rich foods, or finding portion control particularly challenging
I would rather see someone exercise and eat nutritiously in order to get an energy boost.
While preclinical or earlier-stage trials in selected populations might still explore the potential of GLP-1 receptor agonists in neurodegeneration, these results serve as a reality check
On rest days take the daily portion during the day
If you are on semaglutide and are experiencing severe nausea, your provider may consider switching you to tirzepatide (Zepbound, Mounjaro), which has a GIP component that can reduce nausea